换一批Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.
第一作者：
Zhengbo,Song
第一单位：
Department of Clinical Trial, Zhejiang Cancer Hospital, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China.
作者：
Zhengbo,Song [1]
;
Ziming,Li [2]
;
Yiping,Zhang [3]
;
Pingli,Wang [4]
;
Liyan,Jiang [2]
;
Yanqiu,Zhao [5]
;
Jianying,Zhou [6]
;
Xicheng,Wang [7]
;
Wu,Zhuang [8]
;
Jianhua,Shi [9]
;
Dingzhi,Huang [10]
;
Xiaomin,Dang [11]
;
Shundong,Cang [12]
;
Yi,Gong [13]
;
Shi,Jin [14]
;
Weiwei,Li [15]
;
Xiaorong,Dong [16]
;
Junping,Zhang [17]
;
Mingfang,Zhao [18]
;
Xiangjiao,Meng [19]
;
Xuewen,Liu [20]
;
Jian,Fang [21]
;
Ping,Wu [22]
;
Junguo,Lu [23]
;
Liangming,Zhang [24]
;
Junquan,Yang [25]
;
Xiang,Wang [26]
;
Hui,Luo [27]
;
Jiuwei,Cui [28]
;
Zhihong,Zhang [29]
;
Jing,Wang [30]
;
Gaofeng,Li [31]
;
Lin,Wu [32]
;
Yan,Yu [33]
;
Yong,Fang [34]
;
Dongqing,Lv [35]
;
Weihua,Yang [36]
;
Lingxiang,Chen [37]
;
Nong,Yang [38]
;
Kunyan,Li [38]
;
Rui,Ma [39]
;
Mingxi,Wang [40]
;
Huan,Zhou [41]
;
Sheng,Hu [42]
;
Qingshan,Li [43]
;
Zhixiang,Zhuang [44]
;
Baoshan,Cao [45]
;
Wei,Zhu [46]
;
Chunwei,Xu [47]
;
Wenjia,Wang [48]
;
Ziyong,Xiang [48]
;
Zhe,Shi [48]
;
Yaolin,Wang [48]
;
Ling,Zhang [48]
;
Shun,Lu [49]
作者单位：
Department of Clinical Trial, Zhejiang Cancer Hospital, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China.
[1]
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
[2]
Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China.
[3]
Department of Respiratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
[4]
Respiratory Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
[5]
Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
[6]
Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
[7]
Department of Thoracic Oncology, Fujian Provincial Cancer Hospital, Fuzhou, China.
[8]
Department of Medical Oncology II, Linyi Cancer Hospital, Linyi, China.
[9]
Pulmonary Oncology Department, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
[10]
Department of Respiratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
[11]
Department of Oncology, Henan Provincial People's Hospital, Zhengzhou, China.
[12]
Department of Phase I Clinical Trial Ward, Chongqing University Cancer Hospital, Chongqing, China.
[13]
Department of Oncology, Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
[14]
Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
[15]
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
[16]
Shanxi Bethune Hospital, The Affiliated Bethune Hospital of Shanxi Medical University, Taiyuan, China.
[17]
Oncology, Medical Ward 2, The First Hospital of China Medical University, Shenyang, China.
[18]
The Four Wards of Thoracic Radiotherapy, Shandong Cancer Hospital, Jinan, China.
[19]
Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, China.
[20]
Department of Thoracic Oncology II, Beijing Cancer Hospital, Beijing, China.
[21]
Department of Oncology, General Hospital of Ningxia Medical University, Yinchuan, China.
[22]
Department of Respiratory Medicine, Nantong Tumor Hospital, Nantong, China.
[23]
Department of Medical Oncology I, Yantai Yuhuangding Hospital, Yantai, China.
[24]
Department 1 of Chemoradiotherapy, Tangshan Cancer Hospital, Tangshan, China.
[25]
Department of Oncology, Xuzhou Central Hospital, Xuzhou, China.
[26]
Department of Thoracic Cancer Radiotherapy, Jiangxi Cancer Hospital, Nanchang, China.
[27]
Oncology Center, Oncology Department, The First Hospital of Jilin University, Changchun, China.
[28]
Respiratory Department, Anhui Provincial Cancer Hospital, Hefei, China.
[29]
Cancer Precision Medicine Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
[30]
Department of Thoracic Surgery, Yunnan Cancer Hospital, Kunming, China.
[31]
Second Department of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China.
[32]
Respiratory Medicine Department, Harbin Medical University Cancer Hospital, Harbin, China.
[33]
Department of Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
[34]
Department of Respiratory and Critical Care Medicine, Taizhou Hospital of Zhejiang Province, Taizhou, China.
[35]
Department of Respiratory Medicine, Shanxi Cancer Hospital, Taiyuan, China.
[36]
Department of Oncology, Jiangsu Cancer Hospital, Nanjing, China.
[37]
Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, Changsha, China.
[38]
Thoracic Medicine Ward Area 2, Liaoning Cancer Hospital & Institute, Shenyang, China.
[39]
Department of Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
[40]
The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
[41]
Department of Thoracic Oncology I, Hubei Cancer Hospital, Wuhan, China.
[42]
Department of Oncology, Affiliated Hospital of Chengde Medical University, Chengde, China.
[43]
Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
[44]
Oncology Chemotherapy and Radiology, Peking University Third Hospital, Beijing, China.
[45]
Department of Oncology, Baotou Central Hospital, Baotou, China.
[46]
Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
[47]
InventisBio Co., Ltd., Shanghai, China.
[48]
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: shunlu@sjtu.edu.cn.
[49]
医学主题词
人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);男(雄)性(Male);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));女(雌)性(Female);中年人(Middle Aged);老年人(Aged);突变(Mutation);成年人(Adult);老年人, 80以上(Aged, 80 and over);嘧啶类(Pyrimidines)
DOI
10.1016/j.ejca.2025.116153
PMID
41330054
发布时间
2026-01-13
- 浏览2
European journal of cancer (Oxford, England
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
